Silexion Therapeutics Corp (SLXN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.29M
Last updated: Nov 17, 2026 at 11:02 AM ET
Earnings
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 68.4% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 27.6, below 30, the oversold line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about SLXN
News
SLXN Valuation
- P/B
- 0.1x
SLXN Profitability: Margins, ROIC and FCF
Silexion Therapeutics (SLXN) has an operating margin of 0.0% and a net margin of 0.0%. It posts a -21349.1% FCF margin.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROE
- -897.0%
- FCF margin
- -21349.1%
Silexion Therapeutics Competitors
The companies most similar to Silexion Therapeutics (SLXN) include Bone Biologics, Scinai Immunotherapeutics and BioRestorative Therapies.
Sector: Healthcare
Companies most similar to Silexion TherapeuticsSLXN Earnings: Beat Rate and Next Report
Silexion Therapeutics (SLXN) beat the EPS estimate in 2 of the 4 most recent quarters that had an estimate (50.0%).
- Beat rate
- 2 of 4 quarters (50.0%)
- Average surprise
- -30.1%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$0.72
Updated Nov 12, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About SLXN
Does SLXN pay dividends?
Silexion Therapeutics Corp (SLXN) does not currently pay a regular dividend.
What is SLXN's market cap?
Silexion Therapeutics Corp (SLXN) has a market capitalization of $1.29M with a current stock price of $1.76.
SLXN pages: Overview, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.